The Oncology Institute, Inc. (TOI)

The Oncology Institute Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 28, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	298	23	150	123	714	-
Market Cap Growth	1207.66%	-84.48%	22.52%	-82.81%	-	-
Enterprise Value	377	99	181	139	808	-
Last Close Price	3.06	0.31	2.04	1.65	9.75	10.80
PE Ratio	-	-	-	1805.81	-	-
PS Ratio	0.57	0.06	0.46	0.49	3.52	-
PB Ratio	-	6.51	2.64	1.00	6.86	-
P/TBV Ratio	-	-	4.72	1.47	12.05	-
EV/Sales Ratio	0.82	0.25	0.56	0.55	3.98	-
Debt / Equity Ratio	-8.44	34.34	2.10	0.88	0.00	0.43
Asset Turnover	2.69	2.06	1.38	1.09	1.51	3.00
Inventory Turnover	27.10	28.62	23.08	25.53	30.05	36.55
Quick Ratio	1.34	1.88	3.62	3.84	4.55	0.81
Current Ratio	1.68	2.15	4.13	4.39	5.17	1.04
Return on Equity (ROE)	-4132.17%	-213.36%	-92.20%	0.13%	-16.52%	-40.73%
Return on Assets (ROA)	-14.99%	-19.67%	-15.97%	-19.35%	-21.08%	-7.81%
Return on Invested Capital (ROIC)	-64.24%	-70.31%	-47.85%	-97.58%	-377.00%	-18.25%
Return on Capital Employed (ROCE)	-41.90%	-49.90%	-34.50%	-31.00%	-26.10%	-21.10%
Earnings Yield	-18.17%	-276.96%	-55.21%	0.12%	-1.53%	-
FCF Yield	-9.14%	-129.89%	-27.17%	-54.80%	-4.98%	-
Buyback Yield / Dilution	-15.14%	-1.76%	8.51%	-21.70%	-12.03%	-

Updated Nov 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q